Prostate cancer patients inform health economics research
CHÉOS Scientists are testing the cost-effectiveness of adding a new blood test to improve prostate cancer screening
Read MoreAugust 28, 2020
CHÉOS Scientists are testing the cost-effectiveness of adding a new blood test to improve prostate cancer screening
Read More
CHÉOS Scientists are testing the cost-effectiveness of a new blood test that aims to avoid the unnecessary health complications and costs of current methods
Read More
CHÉOS Scientists Dr. Aslam Anis and Dr. Wei Zhang conducted a cost-effectiveness analysis comparing three Down syndrome screening techniques, published this week in PLoS One
Read More
Read about the Scientists and research that appeared in the media over the month.
Read More